Samuel D. Colella

Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA.

Argonaut Technologies, Inc. develops, manufactures, and markets products that enable chemists to use high speed parallel synthesis in the development of new drugs

Pharmacopeia LLC develops small molecule therapeutics to address significant medical needs. The firm operates as clinical development stage Biopharmaceutical Company which focuses on discovering and developing novel small molecule therapeutics to address medical needs. The company was founded by John J. Baldwin in February 2002 and is headquartered in Cranbury, NJ.

Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA.

Alexza Pharmaceuticals, Inc. is a pharmaceutical company. It focused on the research, development and commercialization of novel proprietary products for the acute treatment of central nervous system conditions. Its product candidates are AZ-002 and AZ-007. The company was founded by Alejandro C. Zaffaroni in 2000 and is headquartered in Mountain View, CA.

Genomic Health, Inc. engages in the provision of genomic-based diagnostic tests. Its tests analyze the underlying biology of cancers, allowing physicians and patients to make individualized treatment decisions. The firm uses a platform which translates a massive amount of clinical and genomic data into clinically actionable results for treatment planning. The company was founded by Patrick F. Terry, Joffre B. Baker, Randal W. Scott, and Steven Shak in August 2000 and is headquartered in Redwood City, CA.

Flexion Therapeutics, Inc. operates as a biopharmaceutical company, which engages in the development and commercialization of novel and local therapies. It specializes in the treatment of patients with musculoskeletal conditions including osteoarthritis. It offers products under the Zilretta brand, an extended-release corticosteroid approved to manage osteoarthritis knee pain. The company was founded by Michael D. Clayman and Neil Bodick on November 5, 2007 and is headquartered in Burlington, MA.

Rennovia, Inc. engaged in the creation of novel processes for the cost advantaged production of commodity and specialty chemicals from renewable feedstocks. It developed processes for the production of biobased glucaric acid, adipic acid, 1,6-hexanediol, hexamethylenediamine (HMD), and other building blocks for a wide range of functional materials. The company was founded by Thomas R. Boussie and Vincent J. Murphy in 2009 and was headquartered in Santa Clara, CA.

Halio, Inc. engages in the development of adaptive glass for the commercial, residential, and automotive markets. It builds products based on dynamic light control technology for connected home, offices, cars and other future applications. The firm also develops technologies applied to building materials for energy efficiency. The company was founded by Howard Turner and Sam Bergh in 2010 and is headquartered in South San Francisco, CA.

Institutional Venture Partners (Institutional Venture Partners) is a venture capital firm founded in 1980 by Reid Dennis. The firm is headquartered in Menlo Park, California.

GenPharm International, Inc. manufactures biopharmaceutical products. The company works towards the application of transgenic animal technology to the development of human antibody products, which are used for therapeutic uses. It was founded in 1988 and is located in San Jose, CA.

Part of River Acquisition Corp., IVAC Holdings, Inc. is an investment and acquisition company. The company is based in San Diego, CA.

Part of Imagyn Medical Technologies, Inc., Imagyn Medical, Inc. is a company that makes micro-invasive devices. The company is based in Laguna Niguel, CA. The company was founded by Steven R. Bacich. Imagyn Medical was acquired by Urohealth Systems, Inc. on September 30, 1997 for $55.49 million.

Versant Venture Management LLC (Versant Ventures) is an independent venture capital firm founded in 1999 by Brian Atwood, Samuel Colella, Bill Link and Ross Jaffe. The firm is headquartered in San Francisco with additional offices in Basel and Vancouver.

Thermage, Inc. manufactures and distributes medical devices. The company is developing innovative aesthetic technologies including its patented capacitive radiofrequency device to achieve a desired cosmetic or therapeutic effecton and under the skin surface. The company was founded in the year 1995 by Edward W. Knowlton and is headquartered in Hayward, CA.

National Venture Capital Association provides business association services. It facilitates networking opportunities and provides research data to its members. The company is headquartered in Washington, DC.

Solta Medical, Inc. designs, develops, manufactures and markets energy-based medical device systems for aesthetic applications. Its brands include Clear + Brilliant pélo, Thermage, Liposonix, VASER, Fraxel, Clear + Brilliant, and Isolaz systems which are used to address various aesthetic issues. The company was founded by Edward W. Knowlton on January 11, 1996 and is headquartered in Pleasanton, CA.

Quanticel Pharmaceuticals, Inc. engaged in the development of medicines for the treatment of cancer. The company was founded by Stephen Quake and Michael Clarke in 2010 and was headquartered in San Francisco, CA.